CAC
IMCC

Cowen and Company’s IM Cannabis IMCC Stock Holding History

Cowen and Company’s Portfolio IMCC Stock Details IMCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,050
Closed -$222K – 703
2021
Q3 		$222K Buy
+1,050
New +$266K 0.01% 250

Other funds holding IMCC

KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cowen and Company's IMCC Position: Q4 2021 in Review

Cowen and Company sold out of IM Cannabis (IMCC) in Q4 2021, closing a stake of 1,050 shares — an estimated $222K sold.

Cowen and Company first reported a position in IMCC in Q3 2021 and held it in 1 quarter. The position peaked at $222K in Q3 2021. 31 funds tracked by Wall St. Rank hold IMCC as of Q4 2021.

  • Cowen and Company reported no remaining IM Cannabis position as of Q4 2021 after selling out during the quarter.
  • Cowen and Company sold 1,050 IM Cannabis shares in Q4 2021, an estimated $222K.
  • Cowen and Company first reported a position in IM Cannabis in Q3 2021 and held it in 1 quarter.
  • Cowen and Company's IM Cannabis position peaked at $222K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held IM Cannabis as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.